Medigus Ltd ADR Performance
| MDGSDelisted Stock | USD 1.73 0.01 0.58% |
The company secures a Beta (Market Risk) of -1.87, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Medigus are expected to decrease by larger amounts. On the other hand, during market turmoil, Medigus is expected to outperform it. Medigus Ltd ADR right now secures a risk of 0.0%. Please verify Medigus Ltd ADR treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Medigus Ltd ADR will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Medigus Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Medigus is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 24 M |
Medigus |
Medigus Relative Risk vs. Return Landscape
If you would invest 173.00 in Medigus Ltd ADR on August 30, 2024 and sell it today you would earn a total of 0.00 from holding Medigus Ltd ADR or generate 0.0% return on investment over 90 days. Medigus Ltd ADR is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Medigus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Medigus Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medigus' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medigus Ltd ADR, and traders can use it to determine the average amount a Medigus' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MDGS |
Based on monthly moving average Medigus is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medigus by adding Medigus to a well-diversified portfolio.
Medigus Fundamentals Growth
Medigus Stock prices reflect investors' perceptions of the future prospects and financial health of Medigus, and Medigus fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medigus Stock performance.
| Return On Equity | -0.31 | |||
| Return On Asset | -0.0663 | |||
| Profit Margin | (0.13) % | |||
| Operating Margin | (0.09) % | |||
| Current Valuation | 65.3 M | |||
| Shares Outstanding | 1.89 M | |||
| Price To Earning | 33.86 X | |||
| Price To Book | 0.15 X | |||
| Price To Sales | 0.04 X | |||
| Revenue | 91.86 M | |||
| EBITDA | (11.99 M) | |||
| Cash And Equivalents | 24.75 M | |||
| Cash Per Share | 1.01 X | |||
| Total Debt | 10.13 M | |||
| Debt To Equity | 0.27 % | |||
| Book Value Per Share | 18.67 X | |||
| Cash Flow From Operations | (5.66 M) | |||
| Earnings Per Share | (8.70) X | |||
| Total Asset | 97.65 M | |||
| Retained Earnings | (85.59 M) | |||
| Current Asset | 46.34 M | |||
| Current Liabilities | 7.23 M | |||
About Medigus Performance
Assessing Medigus' fundamental ratios provides investors with valuable insights into Medigus' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Medigus is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel. Medigus operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.Things to note about Medigus Ltd ADR performance evaluation
Checking the ongoing alerts about Medigus for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medigus Ltd ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medigus Ltd ADR is now traded under the symbol XYLO. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Medigus Ltd ADR is not yet fully synchronised with the market data | |
| Medigus Ltd ADR may become a speculative penny stock | |
| Medigus Ltd ADR has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 91.86 M. Net Loss for the year was (10.1 M) with profit before overhead, payroll, taxes, and interest of 4.8 M. | |
| Medigus Ltd ADR currently holds about 24.75 M in cash with (5.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01. |
- Analyzing Medigus' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medigus' stock is overvalued or undervalued compared to its peers.
- Examining Medigus' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medigus' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medigus' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medigus' stock. These opinions can provide insight into Medigus' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Medigus Stock
If you are still planning to invest in Medigus Ltd ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigus' history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |